Eric Nuermberger and Justin Hanes of Johns Hopkins University in the U.S. propose to encapsulate vaccine components into nanoparticles that can slip through the mucus barriers lining the respiratory and gastrointestinal tracts to deliver their payload to cells responsible for immune responses. This technology may result in more effective and better tolerated oral and inhaled tuberculosis vaccines.
Grant ID
OPP1067828
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False